Inicio>>Signaling Pathways>> Tyrosine Kinase>> IGF1R>>Ganitumab

Ganitumab (Synonyms: AMG 479; Human Anti-IGF1R Recombinant Antibody)

Catalog No.GC69149

Ganitumab (AMG 479) is a monoclonal antibody that targets the human type 1 insulin-like growth factor receptor (IGF1R). Ganitumab recognizes mouse IGF1R with sub-nanomolar affinity (KD=0.22 nM) and inhibits the interaction between mouse IGF1R and IGF1 and IGF2. Ganitumab can be used for cancer research.

Products are for research use only. Not for human use. We do not sell to patients.

Ganitumab Chemical Structure

Cas No.: 905703-97-1

Tamaño Precio Disponibilidad Cantidad
5mg
936,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Reseñas

Review for Ganitumab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Ganitumab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.